Febuxostat (Ranbaxy Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Febuxostat drug offered from Ranbaxy Pharmaceuticals Inc.. This Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Febuxostat |
| SUBSTANCE NAME: | FEBUXOSTAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-01-17 |
| END MARKETING DATE: | 0000-00-00 |
Febuxostat HUMAN PRESCRIPTION DRUG Details:
| Item Description | Febuxostat from Ranbaxy Pharmaceuticals Inc. |
| LABELER NAME: | Ranbaxy Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/1) |
| START MARKETING DATE: | 2015-01-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63304-864_d618acad-1835-4148-a345-aa1054c367ff |
| PRODUCT NDC: | 63304-864 |
| APPLICATION NUMBER: | ANDA205392 |
Other FEBUXOSTAT Pharmaceutical Manufacturers / Labelers:
